与FGFR抑制剂相关的不良事件的临床发展和管理
Vivek Subbiah1, Srdan Verstovsek2
1Sarah Cannon Research Institute, Nashville, TN, USA.
Cell reports. Medicine
|September 27, 2023
概括
纤维细胞生长因子受体 (FGFR) 抑制剂如erdafitinib具有可控的毒性. 积极的监测和特定的治疗有助于管理副作用,如高酸血症和皮肤问题,确保最佳的临床益处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 已批准的纤维细胞生长因子受体 (FGFR) 抑制剂包括erdafitinib,pemigatinib和futibatinib.
- 这些向治疗提供了显著的临床益处,但与特定的毒性有关.
研究的目的:
- 审查与FGFR抑制剂相关的最常见的毒性.
- 为这些不良事件提供实际的管理策略.
主要方法:
- 对已批准的FGFR抑制剂的毒性和管理策略的文献综述.
- 对常见不良事件的预防措施和治疗选择的总结.
主要成果:
- 常见的毒性包括高酸血症,眼部事件,皮肤问题 (脱发,皮肤干燥,手脚综合征) 和胃肠道问题 (腹,口炎,口腔干燥).
- 管理策略包括剂量调整,预防性饮食,局部治疗和像洛佩拉胺和米诺西迪尔这样的药物.
结论:
- 大多数与FGFR抑制剂相关的毒性可以通过适当的干预来控制.
- 积极的监测和及时管理对于优化临床效益和患者结果至关重要.
关键词:
一个FGFR1.在FGFR2中.在FGFR3中.在FGFR4中.不良事件不良事件不良事件赫达菲提尼布 (herdafitinib) 是一种药物.纤维细胞生长因子受体没有Futibatinib.管理的管理管理的管理.佩米加丁尼布 (Pemigatinib) 是一种更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.9K
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
7.7K
相关概念视频
Pharmacovigilance
876
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
876
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Administration and Therapy Phases: Overview
504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
